SCHEMBL15912979

SCHEMBL15912979

CCc1cccc(F)c1O[Si](C)(C)C(C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.37
GABRB2 P47870 2/20 0.37
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
ALOX5AP P20292 2/20 0.35
FEN1 P39748 2/20 0.35
RIPK1 Q13546 3/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
LMNA P02545 1/20 0.34
POLB P06746 1/20 0.34
IDO1 P14902 2/20 0.33
PREP P48147 2/20 0.33
ADRA2A P08913 1/20 0.32
ADRA2B P18089 1/20 0.32
ADRA2C P18825 1/20 0.32
MEN1 O00255 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
KMT2A Q03164 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6938316 0.84 ALOX5AP (0.41) ALOX5APFEN1PREP
SCHEMBL28444374 0.82 ALOX5AP (0.32) ALOX5APFEN1
SCHEMBL15912814 0.78 ALOX5AP (0.38) ALOX5APFEN1
SCHEMBL15912665 0.78 ACHE (0.39) SLC6A2SLC6A4ALOX5APFEN1PREP
SCHEMBL8877521 0.77 ALOX5AP (0.37) ALOX5APFEN1PREP
SCHEMBL15912811 0.77 FEN1 (0.49) GABRA1GABRB2ALOX5APFEN1
SCHEMBL14920085 0.77 ALOX5AP (0.37) SLC6A2SLC6A4ALOX5APFEN1LMNA
SCHEMBL8693680 0.74 ELANE (0.34) GABRA1GABRB2ALOX5APFEN1PREP
SCHEMBL12648278 0.73 SLC6A2 (0.43) GABRA1GABRB2SLC6A2SLC6A4L3MBTL1
SCHEMBL15912855 0.73 ALOX5AP (0.35) ALOX5APFEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2951169-B1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2019-08-28 EP disclosed
US-9926333-B2 Flap modulators JANSSEN PHARMACEUTICA NV (BE) 2018-03-27 US disclosed
US-20170327514-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2017-11-16 US disclosed
US-9732093-B2 FLAP modulators JANSSEN PHARMACEUTICA NV (BE) 2017-08-15 US disclosed
US-20150368270-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2015-12-24 US disclosed
US-20150252008-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2015-09-10 US disclosed
US-9073876-B2 Flap modulators JANSSEN PHARMACEUTICA NV (BE) 2015-07-07 US disclosed
US-20140221310-A1 FLAP MODULATORS JANSSEN PHARMACEUTICA NV (US) 2014-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170327514-A1 FLAP MODULATORS FEN1, PGF, TBXA2R GABRA1 2546/4885GABRB2 2496/4885SLC6A2 4669/4885
US-20140221310-A1 FLAP MODULATORS FEN1, PGF, PTGIS GABRA1 2807/4885GABRB2 2621/4885SLC6A2 4761/4885
US-20150368270-A1 FLAP MODULATORS FEN1, PGF, TBXA2R GABRA1 2546/4885GABRB2 2496/4885SLC6A2 4669/4885
US-20150252008-A1 FLAP MODULATORS FEN1, PGF, PTGIS GABRA1 2807/4885GABRB2 2621/4885SLC6A2 4761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.